Bay Area exterior building

AbbVie At a Glance

AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people’s lives.

A Closer Look at Our Impact
ESG ACTION REPORT

AbbVie’s commitment to and progress on environmental, social and governance goals are outlined in this comprehensive 2025 report. 


10-Year Impact Report

See highlights from the past 10 years through our growth as a company and impact with patients, science, jobs, and communities.


ANNUAL REPORT

For more information on AbbVie’s financial performance download the 2025 Annual Report.

~57K

employees in
70+ countries



250+

partnerships with leading biotechs, universities, nonprofits and government organizations to advance science



~20

countries with R&D and/or manufacturing facilities



$25M

raised for ~13,000 nonprofit organizations through our Employee Giving Campaign



12

blockbuster products with 2025 net revenues greater than $1B


75+

conditions treated across
all stages of life



~90

compounds, devices or indications
in development individually
or under collaboration or license



~74M

~74 million patients reached
with AbbVie products in 2025



~180

countries and territories
where AbbVie products
help patients



$85B+

invested in adjusted R&D
since 2013



* Adjusted R&D investment is a non-GAAP measure, which is reconciled in our 2026 Proxy Statement


Our work gets noticed

We’ve been honored to receive some of the most prestigious ratings and recognitions in the industry, including being named on more than 40 great workplace and diversity and inclusion lists. 


External recognition as a top company